Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CUE
CUE BIOPHARMA, INC.
NASDAQ
$27.88
▼ DOWN 0.99% (-0.28)

KEY STATISTICS

Market Cap$73.27 M
52w High$45.50
52w Low$4.98
Dividend Yield—
Frequency—
P/E-1.03
Volume102.25K
Shares Out.2.63M

COMPANY

LEADERSHIP

Shao-Lee Lin
CHIEF EXECUTIVE
Shao-Lee Lin

COMPENSATION 2026

Salary$240,504
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$849,124
Total$1,426,183

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 2, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
29

PRICE TARGET

Target High$7.00
Target Low$2.00
Target Median$4.00
Target Consensus$4.33

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$1.55M
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2026-04-24Reverse1:30

PRICE

$27.88 ▼ DOWN 0.99% (−$0.28)
OVERLAYS
$28.00$28.50$29.00$29.509:35 AM10:39 AM11:43 AM12:47 PM1:51 PM2:55 PM3:59 PM27.88

About Cue Biopharma, Inc.

https://www.cuebiopharma.com ↗

Cue Biopharma, a Cambridge-based clinical-stage biotech, develops biologic immunotherapies for cancers, infectious diseases, and autoimmune disorders, with lead candidates like CUE-101 targeting antigen-specific T cells, and collaborates with Merc...

INDUSTRY

Biotechnology

A PRODUCT CUE BIOPHARMA, INC. IS KNOWN FOR

CUE-101
CUE-101

CUE-101, Cue Biopharma's lead clinical-stage injectable biologic, targets HPV-driven cancers by activating T cells, and remains its most advanced candidate despite a strategic shift to autoimmune therapies.

COMPETITORS

COMPETITOR
AMGN COMPARE
HOWL COMPARE
JANX COMPARE
NKTR COMPARE
XLO COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
20
LISTED HERE
6
RANKED BY POSITION SIZE
VTI
0.00% · 111.9K
SILX
0.34% · 13.8K
IWC
0.02% · 11.3K
GERM
0.07% · 10.8K
DFAS
0.00% · 1.8K
AVSC
0.00% · 301

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
85
TOP 12 OF 85 · RANKED BY POSITION SIZE
Bleichroeder LP
6.8M sh · $1.57M
Catalytic Wealth Ria, LLC
4.6M sh · $1.06M
Vanguard Group Inc
3.0M sh · $2.19M
Lion Point Capital, LP
2.2M sh · $506.44K
Geode Capital Management, LLC
1.1M sh · $244.8K
Blackrock Inc.
756.7K sh · $938.35K
Boothbay Fund Management, LLC
704.3K sh · $215.09K
Robertson Stephens Wealth Management, LLC
478.5K sh · $110.01K
Blackrock, Inc.
449.2K sh · $137.17K
Texas Capital Bank Wealth Management Services Inc
440.7K sh · $134.58K
Bank Of America Corp /De/
324.5K sh · $233K
Angeles Wealth Management, LLC
310.0K sh · $71.27K

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
DIRECTOR
Sarraf Pasha
Purchase · 18.4K shares
2026-07-09
★
DIRECTOR
Garzone Pamela
Purchase · 18.9K shares
2026-07-09
★
OFFICER: VP, PRIN. ACCOUNTING OFFICER
Meluzio Michael Vincent
Sale · 3 shares
2026-08-13
★
OFFICER, OTHER: CHIEF LEGAL COMPLIANCE OFFICER
Ray Sumita
Sale · 6.4K shares
2026-08-13

SECTORS PEERS

PEERPRICE
IPSC$2.02COMPARE
SPRB$60.78COMPARE
EQ$2.39COMPARE
OTLK$0.64COMPARE
NRXP$3.55COMPARE
BRNS$0.75COMPARE
SNTI$0.38COMPARE
MDCX$0.26COMPARE